These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1958786)

  • 21. Editorial: Isoniazid-associated hepatitis. Reconsideration of the indications for administration of isoniazid.
    Israel HL
    Gastroenterology; 1975 Aug; 69(2):539-42. PubMed ID: 1150056
    [No Abstract]   [Full Text] [Related]  

  • 22. Isoniazid-associated hepatitis deaths: a review of available information.
    Israel HL; Gottlieb JE
    Am Rev Respir Dis; 1992 Dec; 146(6):1643; author reply 1644. PubMed ID: 1456590
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid-associated hepatitis. Report of an outbreak.
    Garibaldi RA; Drusin RE; Ferebee SH; Gregg MB
    Am Rev Respir Dis; 1972 Sep; 106(3):357-65. PubMed ID: 5080707
    [No Abstract]   [Full Text] [Related]  

  • 25. Isoniazid-associated hepatitis deaths: a review of available information.
    Snider DE; Caras GJ
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):494-7. PubMed ID: 1736764
    [No Abstract]   [Full Text] [Related]  

  • 26. Fulminant isoniazid-induced hepatitis: the hazards of ex-adiuvantibus treatment in the elderly.
    Pentimone F; Del Corso L
    Panminerva Med; 1994 Dec; 36(4):206-8. PubMed ID: 7603741
    [No Abstract]   [Full Text] [Related]  

  • 27. [Toxic hepatitis (liver and antitubercular drugs)].
    Kohan S
    Acta Gastroenterol Latinoam; 1977 Dec; 7(4):301-4. PubMed ID: 617560
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
    Derveaux L; Demedts M; Fevery J; Gyselen A
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis induced by isoniazid].
    Noya M; Castillo J; Lema M; Alvarez-Prechous A
    Rev Clin Esp; 1974 Jun; 133(6):525-30. PubMed ID: 4438705
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical Grand Rounds from the Dempsey Hospital of the University of Connecticut. Iatrogenic liver disease. INH hepatitis.
    Scheig R
    Conn Med; 1978 Nov; 42(11):715-9. PubMed ID: 710128
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug-induced active hepatitis (author's transl)].
    Labayle D; Lenoir C; Buffet C; Chaput JC; Etienne P
    Nouv Presse Med; 1979 Jun; 8(24):2013-5. PubMed ID: 386256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis].
    Volosevich GV
    Probl Tuberk; 1989; (9):72-3. PubMed ID: 2587561
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatotoxicity caused by isoniazid].
    Castillo J; Lema M; Cameselle L; Al-Shaban W; Cerviño L; Salgueiro M; Noya M
    Rev Esp Enferm Apar Dig; 1981 Dec; 60(6):595-602. PubMed ID: 7330425
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute hepatitis caused by voluntary poisoning with isoniazid].
    Manchon ND; Joubert M; Chassagne P; Duranton Y; Moore ND; Hémet J; Bercoff E; Boureille J
    Gastroenterol Clin Biol; 1990; 14(2):184-5. PubMed ID: 2328884
    [No Abstract]   [Full Text] [Related]  

  • 35. Liver enzyme disturbances during isoniazid chemoprophylaxis in children.
    Beaudry PH; Brickman HF; Wise MB; MacDougall D
    Am Rev Respir Dis; 1974 Nov; 110(5):581-4. PubMed ID: 4429254
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reversible acute hepatic failure after treatment with association of isoniazide-rifampicin (author's transl)].
    Le Guillou M; L'Henaff F; Boisseau M; Castaing Y; Bourdalle-Badie C
    Sem Hop; 1981 Jun 18-25; 57(25-28):1199-201. PubMed ID: 6266037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis and antitubercular therapy.
    Mahashur AA; Prabhudesai PP
    J Assoc Physicians India; 1991 Aug; 39(8):595-6. PubMed ID: 1814871
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis on high dose isoniazid: reintroduction of the drug in severe tuberculous meningitis.
    Danielides IC; Constantoulakis M; Daikos GK
    Am J Gastroenterol; 1983 Jun; 78(6):378-80. PubMed ID: 6859018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: The competing risks of tuberculosis and hepatitis for adult tuberculin reactors.
    Moulding TS
    Am Rev Respir Dis; 1975 Oct; 112(4):581-2. PubMed ID: 1200492
    [No Abstract]   [Full Text] [Related]  

  • 40. Isoniazid prophylaxis and deaths in Baltimore, Maryland 1972.
    Levin ML; Moodie AS
    Bull Int Union Tuberc; 1976; 51(1):213-23. PubMed ID: 1030285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.